These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 28463758)

  • 1. Prospective evaluation of serum anti-Müllerian hormone dynamics in 250 women of reproductive age treated with chemotherapy for breast cancer.
    Dezellus A; Barriere P; Campone M; Lemanski C; Vanlemmens L; Mignot L; Delozier T; Levy C; Bendavid C; Debled M; Bachelot T; Jouannaud C; Loustalot C; Mouret-Reynier MA; Gallais-Umbert A; Masson D; Freour T
    Eur J Cancer; 2017 Jul; 79():72-80. PubMed ID: 28463758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Anti-Mullerian Hormone Levels, Antral Follicle Counts, and Mean Ovarian Volumes in Chemotherapy-Induced Amenorrhea among Breast Cancer Patients: A Prospective Clinical Study.
    Ünal Ç; Ordu Ç; Özmen T; İlgun AS; Çelebi F; Baysal B; Özkurt E; Duymaz T; Erdoğan İyigün Z; Kurt S; Öztürk MA; Pilancı KN; Alço G; Yararbaş K; Kayan Tapan T; Güven DC; Soybir G; Özmen V
    Curr Oncol; 2023 Oct; 30(10):9217-9229. PubMed ID: 37887566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-Dense Chemotherapy Regimen for Breast Cancer Associated with Significant Decline in Ovarian Reserve.
    Chamani IJ; Gannon A; Connell PT; Bisen A; Kovanci E; Sangi-Haghpeykar H; Woodard T; McKenzie LJ
    J Adolesc Young Adult Oncol; 2024 Jun; 13(3):465-468. PubMed ID: 38112555
    [No Abstract]   [Full Text] [Related]  

  • 4. A prospective cohort study with serum anti-mullerian hormone levels change in patients undergoing uterine preservation after gestational trophoblastic neoplasia treatment with a methotrexate regimen.
    Tuan Dat D; Huyen Thuong PT; Hong Hai D; Khac Toan N; Tai Duc N; Duy Anh N; Thi Thu Ha N
    Clin Ter; 2024; 175(2):128-134. PubMed ID: 38571471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Clinical Value and Interpretation of Anti-Müllerian Hormone in Women With Cancer.
    Anderson RA; Su HI
    Front Endocrinol (Lausanne); 2020; 11():574263. PubMed ID: 33117288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protective effect of vitamin D on ovarian reserve and anti-mullerian hormone in patients undergoing chemotherapy for breast cancer, a randomized phase ΙΙ clinical trial.
    Dastmardi Z; Lashkari M; Saeedian A; Aghili M; Alipour S
    Cancer Rep (Hoboken); 2024 Jun; 7(6):e2104. PubMed ID: 38925607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective longitudinal analysis of the predictors of amenorrhea after breast cancer chemotherapy: Impact of BRCA pathogenic variants.
    Oktay KH; Turan V; Bedoschi G; Abdo N; Bang H; Goldfarb S
    Cancer Med; 2023 Sep; 12(18):19225-19233. PubMed ID: 37698031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term antimüllerian hormone patterns differ by cancer treatment exposures in young breast cancer survivors.
    Zhou B; Kwan B; Desai MJ; Nalawade V; Ruddy KJ; Nathan PC; Henk HJ; Murphy JD; Whitcomb BW; Su HI
    Fertil Steril; 2022 May; 117(5):1047-1056. PubMed ID: 35216831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effect of chemotherapy after ovarian decortication on the ovarian function in women surviving cancer.
    Ortiz E; Peña CJ; Hidalgo JJ; Monllor-Tormos A; Zolfaroli I; Vila MJ; Sánchez-Serrano M; Pellicer A; Cano A
    J Assist Reprod Genet; 2023 Dec; 40(12):2827-2834. PubMed ID: 37755614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling Variation in the Reproductive Lifespan of Female Adolescent and Young Adult Cancer Survivors Using AMH.
    Su HI; Kwan B; Whitcomb BW; Shliakhsitsava K; Dietz AC; Stark SS; Martinez E; Sluss PM; Sammel MD; Natarajan L
    J Clin Endocrinol Metab; 2020 Aug; 105(8):2740-51. PubMed ID: 32270202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in markers of ovarian reserve and endocrine function in young women with breast cancer undergoing adjuvant chemotherapy.
    Yu B; Douglas N; Ferin MJ; Nakhuda GS; Crew K; Lobo RA; Hershman DL
    Cancer; 2010 May; 116(9):2099-105. PubMed ID: 20187091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ProFertil study protocol for the investigation of gonadotropin-releasing hormone agonists (GnRHa) during chemotherapy aiming at fertility protection of young women and teenagers with cancer in Sweden-a phase III randomised double-blinded placebo-controlled study.
    Rodriguez-Wallberg KA; Nilsson HP; Bergh J; Malmros J; Ljungman P; Foukakis T; Stragliotto CL; Friman EI; Linderholm B; Valachis A; Andersson A; Harrysson S; Vennström L; Frisk P; Mörse H; Eloranta S
    BMJ Open; 2023 Dec; 13(12):e078023. PubMed ID: 38070906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A New Model Including AMH Cut-off Levels to Predict Post-treatment Ovarian Function in Early Breast Cancer: A Prospective Cohort Study.
    Omranipour R; Ahmadi-Harchegani F; Saberi A; Moini A; Shiri M; Jalaeefar A; Arian A; Seifollahi A; Madani M; Eslami B; Alipour S
    Arch Iran Med; 2024 Feb; 27(2):96-104. PubMed ID: 38619033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum anti-Müllerian hormone is lower in patients with multiple radioiodine dose for treatment of pediatric thyroid cancer.
    Barreto MCA; Treistman N; Cavalcante LBCP; Bulzico D; de Andrade FA; Corbo R; Alves Junior PAG; Vaisman F
    Eur Thyroid J; 2024 Apr; 13(2):. PubMed ID: 38290210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effects of Chemotherapy on the Levels of Serum Anti-Müllerian Hormone in Patients with Gestational Trophoblastic Neoplasia.
    Zamani M; Mohsenpour F; Torkzaban F; Atrvash N; Majlesi A; Torkzaban A
    J Reprod Infertil; 2023; 24(1):43-48. PubMed ID: 36919051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What reproductive follow-up for adolescent and young women after cancer? A review.
    Decanter C; Elefant E; Poirot C; Courbiere B
    Reprod Biomed Online; 2024 Jul; 49(1):103891. PubMed ID: 38761433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum androgen dynamics in young women aged 18-40 treated with chemotherapy for breast cancer: an observational, multicentric, prospective study in France.
    Loubersac S; Chaillot M; Reignier A; Lefebvre T; Dezellus A; Colombel A; Barriere P; Masson D; Freour T
    Hum Fertil (Camb); 2024 Dec; 27(1):2350758. PubMed ID: 38957151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leuprolide Protects Ovarian Reserve in Adolescents Undergoing Gonadotoxic Therapy.
    Hoyos-Martinez A; Scheurer ME; Allen-Rhoades W; Okcu MF; Horne VE
    J Adolesc Young Adult Oncol; 2023 Dec; 12(6):828-834. PubMed ID: 36976803
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-Müllerian hormone in African-American women with systemic lupus erythematosus.
    Angley M; Spencer JB; Lim SS; Howards PP
    Lupus Sci Med; 2020 Nov; 7(1):. PubMed ID: 33132225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Müllerian hormone levels and breast cancer risk in the study of women's health across the nation.
    Grimes NP; Bertone-Johnson ER; Whitcomb BW; Sievert LL; Crawford SL; Gold EB; Avis NE; Greendale GA; Santoro N; Habel LA; Reeves KW
    Cancer Causes Control; 2022 Aug; 33(8):1039-1046. PubMed ID: 35768642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.